These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 16466747

  • 1. The effects of oral Cardax (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on 5-lipoxygenase in vitro and in vivo.
    Lockwood SF, Penn MS, Hazen SL, Bikádi Z, Zsila F.
    Life Sci; 2006 Jun 06; 79(2):162-74. PubMed ID: 16466747
    [Abstract] [Full Text] [Related]

  • 2. Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax).
    Gross GJ, Lockwood SF.
    Life Sci; 2004 May 28; 75(2):215-24. PubMed ID: 15120573
    [Abstract] [Full Text] [Related]

  • 3. Plasma appearance and tissue accumulation of non-esterified, free astaxanthin in C57BL/6 mice after oral dosing of a disodium disuccinate diester of astaxanthin (Heptax).
    Showalter LA, Weinman SA, Østerlie M, Lockwood SF.
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Mar 28; 137(3):227-36. PubMed ID: 15171947
    [Abstract] [Full Text] [Related]

  • 4. Seven day oral supplementation with Cardax (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats.
    Gross GJ, Hazen SL, Lockwood SF.
    Mol Cell Biochem; 2006 Feb 28; 283(1-2):23-30. PubMed ID: 16444582
    [Abstract] [Full Text] [Related]

  • 5. Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: a study in mice.
    Tripathi DN, Jena GB.
    Chem Biol Interact; 2009 Aug 14; 180(3):398-406. PubMed ID: 19539803
    [Abstract] [Full Text] [Related]

  • 6. Disodium disuccinate astaxanthin (Cardax): antioxidant and antiinflammatory cardioprotection.
    Lockwood SF, Gross GJ.
    Cardiovasc Drug Rev; 2005 Aug 14; 23(3):199-216. PubMed ID: 16252014
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
    Pashkow FJ, Watumull DG, Campbell CL.
    Am J Cardiol; 2008 May 22; 101(10A):58D-68D. PubMed ID: 18474276
    [Abstract] [Full Text] [Related]

  • 9. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice.
    Hougee S, Hartog A, Sanders A, Graus YM, Hoijer MA, Garssen J, van den Berg WB, van Beuningen HM, Smit HF.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):264-9. PubMed ID: 16405885
    [Abstract] [Full Text] [Related]

  • 10. Acute and chronic administration of disodium disuccinate astaxanthin (Cardax) produces marked cardioprotection in dog hearts.
    Gross GJ, Lockwood SF.
    Mol Cell Biochem; 2005 Apr 15; 272(1-2):221-7. PubMed ID: 16010990
    [Abstract] [Full Text] [Related]

  • 11. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007 Apr 15; 26 Suppl 1():3-106. PubMed ID: 17365137
    [Abstract] [Full Text] [Related]

  • 12. Retrometabolic syntheses of astaxanthin (3,3'-dihydroxy-beta,beta-carotene-4,4'-dione) conjugates: a novel approach to oral and parenteral cardio-protection.
    Lockwood SF, Jackson HL, Gross GJ.
    Cardiovasc Hematol Agents Med Chem; 2006 Oct 15; 4(4):335-49. PubMed ID: 17073610
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association studies of aggregated aqueous lutein diphosphate with human serum albumin and alpha1-acid glycoprotein in vitro: evidence from circular dichroism and electronic absorption spectroscopy.
    Zsila F, Nadolski G, Lockwood SF.
    Bioorg Med Chem Lett; 2006 Jul 15; 16(14):3797-801. PubMed ID: 16678417
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
    Lorrain DS, Bain G, Correa LD, Chapman C, Broadhead AR, Santini AM, Prodanovich P, Darlington JV, Hutchinson JH, King C, Lee C, Baccei C, Li Y, Arruda JM, Evans JF.
    J Pharmacol Exp Ther; 2009 Dec 15; 331(3):1042-50. PubMed ID: 19749079
    [Abstract] [Full Text] [Related]

  • 16. Lipid peroxidation in mice fed a choline-deficient diet as evaluated by total hydroxyoctadecadienoic acid.
    Yoshida Y, Itoh N, Hayakawa M, Habuchi Y, Inoue R, Chen ZH, Cao J, Cynshi O, Niki E.
    Nutrition; 2006 Mar 15; 22(3):303-11. PubMed ID: 16500556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model.
    Mizuno M, Ito Y, Hepburn N, Mizuno T, Noda Y, Yuzawa Y, Harris CL, Morgan BP, Matsuo S.
    J Immunol; 2009 Jul 15; 183(2):1403-12. PubMed ID: 19553534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.